The litigation, filed in the Southern District of New York, covers shareholders who purchased iTonic stock between September 5, 2024, and July 29, 2025. According to the complaint, the company’s underwriters and auditor allegedly facilitated a microcap structure prone to fabricated deal rumors—specifically false reports involving Gilead Sciences—that mirrored previous market failures. While the company eventually disavowed the rumors, the lawsuit claims the damage to investors was preventable had the risks been clearly articulated in public filings.
iTonic Shareholders File Class Action Over 95% Stock Collapse
Investors are targeting iTonic Holdings Ltd and its underwriters in a federal class action, alleging the firm failed to disclose known manipulation risks before its share price cratered by 95% in a single session. The suit centers on whether professional participants ignored patterns seen in previous, failed microcap offerings.
Joseph E. Levi of Levi & Korsinsky, LLP, argues that standard volatility warnings were insufficient to address the specific promotional risks inherent in the firm's small float and offshore-concentrated voting power. The court has set September 29, 2026, as the deadline for investors to apply for lead plaintiff status. With the stock falling from heights that reached $32.00 intraday to near-total collapse, the case seeks to recover losses for those who acquired shares during the period of alleged inflation.
Comments (0)
No comments yet. Be the first!